MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27

investorplace2021-04-27

MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasdaq Exchangethis week, where it will trade as MNMD stock. The company’s announcement thatit will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. Investors can expect to see these numbers continuing through Monday as the listing grows closer.

As investors’ excitement continues to build over the burgeoning industry, there is a key theme to watch. Specifically, the listing of MindMed on the Nasdaq signifies a rapid shift in interest over psychedelics.

With that in mind, here’s everything investors need to know ahead of the MNMD stock uplisting:

What to Know About MindMed and MNMD Stock Now

MindMed offers therapeutic and medicinal treatments for adults.
The company seeks to treat symptoms primarily of ADHD, anxiety and opioid dependence.

MindMed is one of the leaders of the psychedelic medicine industry, a booming sector in the wake of theincreasing decriminalization of psychedelic substances.
Subordinate voting shares were approved on Friday.
The listing will take place tomorrow, April 27.
MMEDF stock is still trading today, but on Tuesday, the stock’s ticker for U.S. investors will change to MNMD.
Trading of the stock will continue on the Neo Exchangefor German and Canadian traders under the ticker MMED.
The listing capitalizes on the growing interest in psilocybin mushrooms. But, the company also produces medicine with ingredients like MDMA, LSD, DMT and 18-MC.
The listing’s news isboosting not just MNMD stock, but also industry peers. Numinus Wellness(OTCMKTS:LKYSF) and Champignon Brands(OTCMKTS:SHRMF) have each gained in the wake of the MNMD stock listing news.

MMEDF stock saw a 65% upswing Friday. At Monday, the stock is already jumping higher, gaining over 37% and trading at $4.80. Trading volume is also already double its norm, with 11 million shares changing hands against the average 2.8 million. The boom has rocketed MMEDF past its previous 52-week high.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

MdNasir
2021-04-27
MdNasir
Excellent
junkow
2021-04-27
junkow
Good
- 48b9b433:
  😀
Mourinho10
2021-04-27
Mourinho10
Nice
Jimmyboy
2021-04-27
Jimmyboy
Good information
Suresh999
2021-04-27
Suresh999
Ok

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1114473252?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-04-27 13:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1114473252","market":"us","top_or_hot":-1,"title":"MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27","media":"investorplace","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock has been climbing recently in anticipation of its uplisting on the<b>Nasdaq Exchange</b>this week, where it will trade as MNMD stock. The company’s announcement thatit will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. Investors can expect to see these numbers continuing through Monday as the listing grows closer.</p><p>As investors’ excitement continues to build over the burgeoning industry, there is a key theme to watch. Specifically, the listing of MindMed on the Nasdaq signifies a rapid shift in interest over psychedelics.</p><p>With that in mind, here’s everything investors need to know ahead of the MNMD stock uplisting:</p><p>What to Know About MindMed and MNMD Stock Now</p><ul><li>MindMed offers therapeutic and medicinal treatments for adults.</li><li>The company seeks to treat symptoms primarily of ADHD, anxiety and opioid dependence.</li></ul><ul><li>MindMed is one of the leaders of the psychedelic medicine industry, a booming sector in the wake of theincreasing decriminalization of psychedelic substances.</li><li>Subordinate voting shares were approved on Friday.</li><li>The listing will take place tomorrow, April 27.</li><li>MMEDF stock is still trading today, but on Tuesday, the stock’s ticker for U.S. investors will change to MNMD.</li><li>Trading of the stock will continue on the&nbsp;<b>Neo Exchange</b>for German and Canadian traders under the ticker MMED.</li><li>The listing capitalizes on the growing interest in psilocybin mushrooms. But, the company also produces medicine with ingredients like MDMA, LSD, DMT and 18-MC.</li><li>The listing’s news isboosting not just MNMD stock, but also industry peers.&nbsp;<b>Numinus Wellness</b>(OTCMKTS:<b><u>LKYSF</u></b>) and&nbsp;<b>Champignon Brands</b>(OTCMKTS:<b><u>SHRMF</u></b>) have each gained in the wake of the MNMD stock listing news.</li></ul><p>MMEDF stock saw a 65% upswing Friday. At Monday, the stock is already jumping higher, gaining over 37% and trading at $4.80. Trading volume is also already double its norm, with 11 million shares changing hands against the average 2.8 million. The boom has rocketed MMEDF past its previous 52-week high.</p>","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-27 13:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasdaq Exchangethis week, where it will trade as MNMD stock. The company’s announcement thatit will be ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/","article_id":"1114473252","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1114473252","pubTimestamp":1619503161,"columns":[],"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasda","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"MNMD股票：MindMed公司4月27日登陆纳斯达克前要知道的9件事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MMEDF":0.9},"content_text":"MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasdaq Exchangethis week, where it will trade as MNMD stock. The company’s announcement thatit will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. Investors can expect to see these numbers continuing through Monday as the listing grows closer.As investors’ excitement continues to build over the burgeoning industry, there is a key theme to watch. Specifically, the listing of MindMed on the Nasdaq signifies a rapid shift in interest over psychedelics.With that in mind, here’s everything investors need to know ahead of the MNMD stock uplisting:What to Know About MindMed and MNMD Stock NowMindMed offers therapeutic and medicinal treatments for adults.The company seeks to treat symptoms primarily of ADHD, anxiety and opioid dependence.MindMed is one of the leaders of the psychedelic medicine industry, a booming sector in the wake of theincreasing decriminalization of psychedelic substances.Subordinate voting shares were approved on Friday.The listing will take place tomorrow, April 27.MMEDF stock is still trading today, but on Tuesday, the stock’s ticker for U.S. investors will change to MNMD.Trading of the stock will continue on the Neo Exchangefor German and Canadian traders under the ticker MMED.The listing capitalizes on the growing interest in psilocybin mushrooms. But, the company also produces medicine with ingredients like MDMA, LSD, DMT and 18-MC.The listing’s news isboosting not just MNMD stock, but also industry peers. Numinus Wellness(OTCMKTS:LKYSF) and Champignon Brands(OTCMKTS:SHRMF) have each gained in the wake of the MNMD stock listing news.MMEDF stock saw a 65% upswing Friday. At Monday, the stock is already jumping higher, gaining over 37% and trading at $4.80. Trading volume is also already double its norm, with 11 million shares changing hands against the average 2.8 million. The boom has rocketed MMEDF past its previous 52-week high.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[{"id":377118282,"gmtCreate":1619504616346,"gmtModify":1634212199104,"author":{"id":"3571373255567067","authorId":"3571373255567067","name":"MdNasir","avatar":"https://static.tigerbbs.com/7f710cb4dfa7ce6c2ad0e54d32ba876c","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3571373255567067","authorIdStr":"3571373255567067"},"htmlText":"Excellent&nbsp;","listText":"Excellent&nbsp;","text":"Excellent","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/377118282","repostId":1114473252,"repostType":4,"repost":{"id":"1114473252","kind":"news","pubTimestamp":1619503161,"share":"https://www.laohu8.com/m/news/1114473252?lang=&edition=full","pubTime":"2021-04-27 13:59","market":"us","language":"en","title":"MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27","url":"https://stock-news.laohu8.com/highlight/detail?id=1114473252","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasda","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock has been climbing recently in anticipation of its uplisting on the<b>Nasdaq Exchange</b>this week, where it will trade as MNMD stock. The company’s announcement thatit will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. Investors can expect to see these numbers continuing through Monday as the listing grows closer.</p><p>As investors’ excitement continues to build over the burgeoning industry, there is a key theme to watch. Specifically, the listing of MindMed on the Nasdaq signifies a rapid shift in interest over psychedelics.</p><p>With that in mind, here’s everything investors need to know ahead of the MNMD stock uplisting:</p><p>What to Know About MindMed and MNMD Stock Now</p><ul><li>MindMed offers therapeutic and medicinal treatments for adults.</li><li>The company seeks to treat symptoms primarily of ADHD, anxiety and opioid dependence.</li></ul><ul><li>MindMed is one of the leaders of the psychedelic medicine industry, a booming sector in the wake of theincreasing decriminalization of psychedelic substances.</li><li>Subordinate voting shares were approved on Friday.</li><li>The listing will take place tomorrow, April 27.</li><li>MMEDF stock is still trading today, but on Tuesday, the stock’s ticker for U.S. investors will change to MNMD.</li><li>Trading of the stock will continue on the&nbsp;<b>Neo Exchange</b>for German and Canadian traders under the ticker MMED.</li><li>The listing capitalizes on the growing interest in psilocybin mushrooms. But, the company also produces medicine with ingredients like MDMA, LSD, DMT and 18-MC.</li><li>The listing’s news isboosting not just MNMD stock, but also industry peers.&nbsp;<b>Numinus Wellness</b>(OTCMKTS:<b><u>LKYSF</u></b>) and&nbsp;<b>Champignon Brands</b>(OTCMKTS:<b><u>SHRMF</u></b>) have each gained in the wake of the MNMD stock listing news.</li></ul><p>MMEDF stock saw a 65% upswing Friday. At Monday, the stock is already jumping higher, gaining over 37% and trading at $4.80. Trading volume is also already double its norm, with 11 million shares changing hands against the average 2.8 million. The boom has rocketed MMEDF past its previous 52-week high.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-27 13:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasdaq Exchangethis week, where it will trade as MNMD stock. The company’s announcement thatit will be ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114473252","content_text":"MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasdaq Exchangethis week, where it will trade as MNMD stock. The company’s announcement thatit will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. Investors can expect to see these numbers continuing through Monday as the listing grows closer.As investors’ excitement continues to build over the burgeoning industry, there is a key theme to watch. Specifically, the listing of MindMed on the Nasdaq signifies a rapid shift in interest over psychedelics.With that in mind, here’s everything investors need to know ahead of the MNMD stock uplisting:What to Know About MindMed and MNMD Stock NowMindMed offers therapeutic and medicinal treatments for adults.The company seeks to treat symptoms primarily of ADHD, anxiety and opioid dependence.MindMed is one of the leaders of the psychedelic medicine industry, a booming sector in the wake of theincreasing decriminalization of psychedelic substances.Subordinate voting shares were approved on Friday.The listing will take place tomorrow, April 27.MMEDF stock is still trading today, but on Tuesday, the stock’s ticker for U.S. investors will change to MNMD.Trading of the stock will continue on the Neo Exchangefor German and Canadian traders under the ticker MMED.The listing capitalizes on the growing interest in psilocybin mushrooms. But, the company also produces medicine with ingredients like MDMA, LSD, DMT and 18-MC.The listing’s news isboosting not just MNMD stock, but also industry peers. Numinus Wellness(OTCMKTS:LKYSF) and Champignon Brands(OTCMKTS:SHRMF) have each gained in the wake of the MNMD stock listing news.MMEDF stock saw a 65% upswing Friday. At Monday, the stock is already jumping higher, gaining over 37% and trading at $4.80. Trading volume is also already double its norm, with 11 million shares changing hands against the average 2.8 million. The boom has rocketed MMEDF past its previous 52-week high.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":377111838,"gmtCreate":1619504466324,"gmtModify":1634212200230,"author":{"id":"3581649737390446","authorId":"3581649737390446","name":"junkow","avatar":"https://static.tigerbbs.com/67ce9c0f4d7bb599e41fc75b34bf8f24","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581649737390446","authorIdStr":"3581649737390446"},"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/377111838","repostId":1114473252,"repostType":4,"repost":{"id":"1114473252","kind":"news","pubTimestamp":1619503161,"share":"https://www.laohu8.com/m/news/1114473252?lang=&edition=full","pubTime":"2021-04-27 13:59","market":"us","language":"en","title":"MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27","url":"https://stock-news.laohu8.com/highlight/detail?id=1114473252","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasda","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock has been climbing recently in anticipation of its uplisting on the<b>Nasdaq Exchange</b>this week, where it will trade as MNMD stock. The company’s announcement thatit will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. Investors can expect to see these numbers continuing through Monday as the listing grows closer.</p><p>As investors’ excitement continues to build over the burgeoning industry, there is a key theme to watch. Specifically, the listing of MindMed on the Nasdaq signifies a rapid shift in interest over psychedelics.</p><p>With that in mind, here’s everything investors need to know ahead of the MNMD stock uplisting:</p><p>What to Know About MindMed and MNMD Stock Now</p><ul><li>MindMed offers therapeutic and medicinal treatments for adults.</li><li>The company seeks to treat symptoms primarily of ADHD, anxiety and opioid dependence.</li></ul><ul><li>MindMed is one of the leaders of the psychedelic medicine industry, a booming sector in the wake of theincreasing decriminalization of psychedelic substances.</li><li>Subordinate voting shares were approved on Friday.</li><li>The listing will take place tomorrow, April 27.</li><li>MMEDF stock is still trading today, but on Tuesday, the stock’s ticker for U.S. investors will change to MNMD.</li><li>Trading of the stock will continue on the&nbsp;<b>Neo Exchange</b>for German and Canadian traders under the ticker MMED.</li><li>The listing capitalizes on the growing interest in psilocybin mushrooms. But, the company also produces medicine with ingredients like MDMA, LSD, DMT and 18-MC.</li><li>The listing’s news isboosting not just MNMD stock, but also industry peers.&nbsp;<b>Numinus Wellness</b>(OTCMKTS:<b><u>LKYSF</u></b>) and&nbsp;<b>Champignon Brands</b>(OTCMKTS:<b><u>SHRMF</u></b>) have each gained in the wake of the MNMD stock listing news.</li></ul><p>MMEDF stock saw a 65% upswing Friday. At Monday, the stock is already jumping higher, gaining over 37% and trading at $4.80. Trading volume is also already double its norm, with 11 million shares changing hands against the average 2.8 million. The boom has rocketed MMEDF past its previous 52-week high.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-27 13:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasdaq Exchangethis week, where it will trade as MNMD stock. The company’s announcement thatit will be ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114473252","content_text":"MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasdaq Exchangethis week, where it will trade as MNMD stock. The company’s announcement thatit will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. Investors can expect to see these numbers continuing through Monday as the listing grows closer.As investors’ excitement continues to build over the burgeoning industry, there is a key theme to watch. Specifically, the listing of MindMed on the Nasdaq signifies a rapid shift in interest over psychedelics.With that in mind, here’s everything investors need to know ahead of the MNMD stock uplisting:What to Know About MindMed and MNMD Stock NowMindMed offers therapeutic and medicinal treatments for adults.The company seeks to treat symptoms primarily of ADHD, anxiety and opioid dependence.MindMed is one of the leaders of the psychedelic medicine industry, a booming sector in the wake of theincreasing decriminalization of psychedelic substances.Subordinate voting shares were approved on Friday.The listing will take place tomorrow, April 27.MMEDF stock is still trading today, but on Tuesday, the stock’s ticker for U.S. investors will change to MNMD.Trading of the stock will continue on the Neo Exchangefor German and Canadian traders under the ticker MMED.The listing capitalizes on the growing interest in psilocybin mushrooms. But, the company also produces medicine with ingredients like MDMA, LSD, DMT and 18-MC.The listing’s news isboosting not just MNMD stock, but also industry peers. Numinus Wellness(OTCMKTS:LKYSF) and Champignon Brands(OTCMKTS:SHRMF) have each gained in the wake of the MNMD stock listing news.MMEDF stock saw a 65% upswing Friday. At Monday, the stock is already jumping higher, gaining over 37% and trading at $4.80. Trading volume is also already double its norm, with 11 million shares changing hands against the average 2.8 million. The boom has rocketed MMEDF past its previous 52-week high.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4147875,"gmtCreate":1619508743987,"gmtModify":1635510057189,"authorId":3581914613506442,"author":{"id":3581914613506442,"idStr":"3581914613506442","authorId":3581914613506442,"name":"48b9b433","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":377111838,"type":1,"supId":0,"prevId":0,"content":"😀","text":"😀","html":"😀"}],"langContent":"EN"},{"id":377119906,"gmtCreate":1619504207905,"gmtModify":1634212201614,"author":{"id":"3552204947633728","authorId":"3552204947633728","name":"Mourinho10","avatar":"https://static.tigerbbs.com/09c0bff118437529aa16b4350b6facdb","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3552204947633728","authorIdStr":"3552204947633728"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/377119906","repostId":1114473252,"repostType":4,"repost":{"id":"1114473252","kind":"news","pubTimestamp":1619503161,"share":"https://www.laohu8.com/m/news/1114473252?lang=&edition=full","pubTime":"2021-04-27 13:59","market":"us","language":"en","title":"MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27","url":"https://stock-news.laohu8.com/highlight/detail?id=1114473252","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasda","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock has been climbing recently in anticipation of its uplisting on the<b>Nasdaq Exchange</b>this week, where it will trade as MNMD stock. The company’s announcement thatit will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. Investors can expect to see these numbers continuing through Monday as the listing grows closer.</p><p>As investors’ excitement continues to build over the burgeoning industry, there is a key theme to watch. Specifically, the listing of MindMed on the Nasdaq signifies a rapid shift in interest over psychedelics.</p><p>With that in mind, here’s everything investors need to know ahead of the MNMD stock uplisting:</p><p>What to Know About MindMed and MNMD Stock Now</p><ul><li>MindMed offers therapeutic and medicinal treatments for adults.</li><li>The company seeks to treat symptoms primarily of ADHD, anxiety and opioid dependence.</li></ul><ul><li>MindMed is one of the leaders of the psychedelic medicine industry, a booming sector in the wake of theincreasing decriminalization of psychedelic substances.</li><li>Subordinate voting shares were approved on Friday.</li><li>The listing will take place tomorrow, April 27.</li><li>MMEDF stock is still trading today, but on Tuesday, the stock’s ticker for U.S. investors will change to MNMD.</li><li>Trading of the stock will continue on the&nbsp;<b>Neo Exchange</b>for German and Canadian traders under the ticker MMED.</li><li>The listing capitalizes on the growing interest in psilocybin mushrooms. But, the company also produces medicine with ingredients like MDMA, LSD, DMT and 18-MC.</li><li>The listing’s news isboosting not just MNMD stock, but also industry peers.&nbsp;<b>Numinus Wellness</b>(OTCMKTS:<b><u>LKYSF</u></b>) and&nbsp;<b>Champignon Brands</b>(OTCMKTS:<b><u>SHRMF</u></b>) have each gained in the wake of the MNMD stock listing news.</li></ul><p>MMEDF stock saw a 65% upswing Friday. At Monday, the stock is already jumping higher, gaining over 37% and trading at $4.80. Trading volume is also already double its norm, with 11 million shares changing hands against the average 2.8 million. The boom has rocketed MMEDF past its previous 52-week high.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-27 13:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasdaq Exchangethis week, where it will trade as MNMD stock. The company’s announcement thatit will be ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114473252","content_text":"MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasdaq Exchangethis week, where it will trade as MNMD stock. The company’s announcement thatit will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. Investors can expect to see these numbers continuing through Monday as the listing grows closer.As investors’ excitement continues to build over the burgeoning industry, there is a key theme to watch. Specifically, the listing of MindMed on the Nasdaq signifies a rapid shift in interest over psychedelics.With that in mind, here’s everything investors need to know ahead of the MNMD stock uplisting:What to Know About MindMed and MNMD Stock NowMindMed offers therapeutic and medicinal treatments for adults.The company seeks to treat symptoms primarily of ADHD, anxiety and opioid dependence.MindMed is one of the leaders of the psychedelic medicine industry, a booming sector in the wake of theincreasing decriminalization of psychedelic substances.Subordinate voting shares were approved on Friday.The listing will take place tomorrow, April 27.MMEDF stock is still trading today, but on Tuesday, the stock’s ticker for U.S. investors will change to MNMD.Trading of the stock will continue on the Neo Exchangefor German and Canadian traders under the ticker MMED.The listing capitalizes on the growing interest in psilocybin mushrooms. But, the company also produces medicine with ingredients like MDMA, LSD, DMT and 18-MC.The listing’s news isboosting not just MNMD stock, but also industry peers. Numinus Wellness(OTCMKTS:LKYSF) and Champignon Brands(OTCMKTS:SHRMF) have each gained in the wake of the MNMD stock listing news.MMEDF stock saw a 65% upswing Friday. At Monday, the stock is already jumping higher, gaining over 37% and trading at $4.80. Trading volume is also already double its norm, with 11 million shares changing hands against the average 2.8 million. The boom has rocketed MMEDF past its previous 52-week high.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":377133270,"gmtCreate":1619503256390,"gmtModify":1634212208135,"author":{"id":"3582072891665879","authorId":"3582072891665879","name":"Jimmyboy","avatar":"https://static.tigerbbs.com/cb9d5d497bceb3edaca216e9eeab3c22","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582072891665879","authorIdStr":"3582072891665879"},"htmlText":"Good information&nbsp;","listText":"Good information&nbsp;","text":"Good information","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/377133270","repostId":1114473252,"repostType":4,"repost":{"id":"1114473252","kind":"news","pubTimestamp":1619503161,"share":"https://www.laohu8.com/m/news/1114473252?lang=&edition=full","pubTime":"2021-04-27 13:59","market":"us","language":"en","title":"MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27","url":"https://stock-news.laohu8.com/highlight/detail?id=1114473252","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasda","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock has been climbing recently in anticipation of its uplisting on the<b>Nasdaq Exchange</b>this week, where it will trade as MNMD stock. The company’s announcement thatit will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. Investors can expect to see these numbers continuing through Monday as the listing grows closer.</p><p>As investors’ excitement continues to build over the burgeoning industry, there is a key theme to watch. Specifically, the listing of MindMed on the Nasdaq signifies a rapid shift in interest over psychedelics.</p><p>With that in mind, here’s everything investors need to know ahead of the MNMD stock uplisting:</p><p>What to Know About MindMed and MNMD Stock Now</p><ul><li>MindMed offers therapeutic and medicinal treatments for adults.</li><li>The company seeks to treat symptoms primarily of ADHD, anxiety and opioid dependence.</li></ul><ul><li>MindMed is one of the leaders of the psychedelic medicine industry, a booming sector in the wake of theincreasing decriminalization of psychedelic substances.</li><li>Subordinate voting shares were approved on Friday.</li><li>The listing will take place tomorrow, April 27.</li><li>MMEDF stock is still trading today, but on Tuesday, the stock’s ticker for U.S. investors will change to MNMD.</li><li>Trading of the stock will continue on the&nbsp;<b>Neo Exchange</b>for German and Canadian traders under the ticker MMED.</li><li>The listing capitalizes on the growing interest in psilocybin mushrooms. But, the company also produces medicine with ingredients like MDMA, LSD, DMT and 18-MC.</li><li>The listing’s news isboosting not just MNMD stock, but also industry peers.&nbsp;<b>Numinus Wellness</b>(OTCMKTS:<b><u>LKYSF</u></b>) and&nbsp;<b>Champignon Brands</b>(OTCMKTS:<b><u>SHRMF</u></b>) have each gained in the wake of the MNMD stock listing news.</li></ul><p>MMEDF stock saw a 65% upswing Friday. At Monday, the stock is already jumping higher, gaining over 37% and trading at $4.80. Trading volume is also already double its norm, with 11 million shares changing hands against the average 2.8 million. The boom has rocketed MMEDF past its previous 52-week high.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-27 13:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasdaq Exchangethis week, where it will trade as MNMD stock. The company’s announcement thatit will be ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114473252","content_text":"MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasdaq Exchangethis week, where it will trade as MNMD stock. The company’s announcement thatit will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. Investors can expect to see these numbers continuing through Monday as the listing grows closer.As investors’ excitement continues to build over the burgeoning industry, there is a key theme to watch. Specifically, the listing of MindMed on the Nasdaq signifies a rapid shift in interest over psychedelics.With that in mind, here’s everything investors need to know ahead of the MNMD stock uplisting:What to Know About MindMed and MNMD Stock NowMindMed offers therapeutic and medicinal treatments for adults.The company seeks to treat symptoms primarily of ADHD, anxiety and opioid dependence.MindMed is one of the leaders of the psychedelic medicine industry, a booming sector in the wake of theincreasing decriminalization of psychedelic substances.Subordinate voting shares were approved on Friday.The listing will take place tomorrow, April 27.MMEDF stock is still trading today, but on Tuesday, the stock’s ticker for U.S. investors will change to MNMD.Trading of the stock will continue on the Neo Exchangefor German and Canadian traders under the ticker MMED.The listing capitalizes on the growing interest in psilocybin mushrooms. But, the company also produces medicine with ingredients like MDMA, LSD, DMT and 18-MC.The listing’s news isboosting not just MNMD stock, but also industry peers. Numinus Wellness(OTCMKTS:LKYSF) and Champignon Brands(OTCMKTS:SHRMF) have each gained in the wake of the MNMD stock listing news.MMEDF stock saw a 65% upswing Friday. At Monday, the stock is already jumping higher, gaining over 37% and trading at $4.80. Trading volume is also already double its norm, with 11 million shares changing hands against the average 2.8 million. The boom has rocketed MMEDF past its previous 52-week high.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":377133976,"gmtCreate":1619503212195,"gmtModify":1634212208597,"author":{"id":"3581644896223732","authorId":"3581644896223732","name":"Suresh999","avatar":"https://static.tigerbbs.com/b75e0b2611994b10d3585f3fd574711f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581644896223732","authorIdStr":"3581644896223732"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/377133976","repostId":1114473252,"repostType":4,"repost":{"id":"1114473252","kind":"news","pubTimestamp":1619503161,"share":"https://www.laohu8.com/m/news/1114473252?lang=&edition=full","pubTime":"2021-04-27 13:59","market":"us","language":"en","title":"MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27","url":"https://stock-news.laohu8.com/highlight/detail?id=1114473252","media":"investorplace","summary":"MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasda","content":"<p><b>MindMed</b>(OTCMKTS:<b><u>MMEDF</u></b>) stock has been climbing recently in anticipation of its uplisting on the<b>Nasdaq Exchange</b>this week, where it will trade as MNMD stock. The company’s announcement thatit will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. Investors can expect to see these numbers continuing through Monday as the listing grows closer.</p><p>As investors’ excitement continues to build over the burgeoning industry, there is a key theme to watch. Specifically, the listing of MindMed on the Nasdaq signifies a rapid shift in interest over psychedelics.</p><p>With that in mind, here’s everything investors need to know ahead of the MNMD stock uplisting:</p><p>What to Know About MindMed and MNMD Stock Now</p><ul><li>MindMed offers therapeutic and medicinal treatments for adults.</li><li>The company seeks to treat symptoms primarily of ADHD, anxiety and opioid dependence.</li></ul><ul><li>MindMed is one of the leaders of the psychedelic medicine industry, a booming sector in the wake of theincreasing decriminalization of psychedelic substances.</li><li>Subordinate voting shares were approved on Friday.</li><li>The listing will take place tomorrow, April 27.</li><li>MMEDF stock is still trading today, but on Tuesday, the stock’s ticker for U.S. investors will change to MNMD.</li><li>Trading of the stock will continue on the&nbsp;<b>Neo Exchange</b>for German and Canadian traders under the ticker MMED.</li><li>The listing capitalizes on the growing interest in psilocybin mushrooms. But, the company also produces medicine with ingredients like MDMA, LSD, DMT and 18-MC.</li><li>The listing’s news isboosting not just MNMD stock, but also industry peers.&nbsp;<b>Numinus Wellness</b>(OTCMKTS:<b><u>LKYSF</u></b>) and&nbsp;<b>Champignon Brands</b>(OTCMKTS:<b><u>SHRMF</u></b>) have each gained in the wake of the MNMD stock listing news.</li></ul><p>MMEDF stock saw a 65% upswing Friday. At Monday, the stock is already jumping higher, gaining over 37% and trading at $4.80. Trading volume is also already double its norm, with 11 million shares changing hands against the average 2.8 million. The boom has rocketed MMEDF past its previous 52-week high.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-27 13:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasdaq Exchangethis week, where it will trade as MNMD stock. The company’s announcement thatit will be ...</p>\n\n<a href=\"https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/04/mnmd-stock-9-things-to-know-before-mindmed-hits-the-nasdaq-on-april-27/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114473252","content_text":"MindMed(OTCMKTS:MMEDF) stock has been climbing recently in anticipation of its uplisting on theNasdaq Exchangethis week, where it will trade as MNMD stock. The company’s announcement thatit will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. Investors can expect to see these numbers continuing through Monday as the listing grows closer.As investors’ excitement continues to build over the burgeoning industry, there is a key theme to watch. Specifically, the listing of MindMed on the Nasdaq signifies a rapid shift in interest over psychedelics.With that in mind, here’s everything investors need to know ahead of the MNMD stock uplisting:What to Know About MindMed and MNMD Stock NowMindMed offers therapeutic and medicinal treatments for adults.The company seeks to treat symptoms primarily of ADHD, anxiety and opioid dependence.MindMed is one of the leaders of the psychedelic medicine industry, a booming sector in the wake of theincreasing decriminalization of psychedelic substances.Subordinate voting shares were approved on Friday.The listing will take place tomorrow, April 27.MMEDF stock is still trading today, but on Tuesday, the stock’s ticker for U.S. investors will change to MNMD.Trading of the stock will continue on the Neo Exchangefor German and Canadian traders under the ticker MMED.The listing capitalizes on the growing interest in psilocybin mushrooms. But, the company also produces medicine with ingredients like MDMA, LSD, DMT and 18-MC.The listing’s news isboosting not just MNMD stock, but also industry peers. Numinus Wellness(OTCMKTS:LKYSF) and Champignon Brands(OTCMKTS:SHRMF) have each gained in the wake of the MNMD stock listing news.MMEDF stock saw a 65% upswing Friday. At Monday, the stock is already jumping higher, gaining over 37% and trading at $4.80. Trading volume is also already double its norm, with 11 million shares changing hands against the average 2.8 million. The boom has rocketed MMEDF past its previous 52-week high.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":11,"commentSize":5,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.5","shortVersion":"4.33.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1114473252"}